Breathe

December

Editorials

Biomarkers in respiratory diseases Claudia C. Dobler Breathe, 15 (4) 265; 10.1183/20734735.0329-2019
Advanced roles in respiratory healthcare science: it's not just spirometry Joanna Shakespeare, Edward Parkes, Melanie Bryce, James Hull Breathe, 15 (4) 267; 10.1183/20734735.0310-2019
Interstitial lung diseases: course report Michael Kreuter, Athol Wells, Deval R. Mehta, Anna Kovchun Breathe, 15 (4) 270; 10.1183/20734735.0259-2019
ß2-agonists do not work in children under 2 years of age: myth or maxim? Fatima Yusuf, Andrew P. Prayle, Michael P. Yanney Breathe, 15 (4) 273; 10.1183/20734735.0255-2019

Patient voice

Biomarker development in asthma from a patient's perspective Dominique Hamerlijnck Breathe, 15 (4) 277; 10.1183/20734735.0303-2019
Patient testimony: hyper-IgE ?syndrome and associated lung ?infections Rachel Orritt, Sandra Hicks Breathe, 15 (4) e131; 10.1183/20734735.0331-2019

Continuous professional development

Continuous professional development: elevating thoracic oncology education in Europe Wouter H. van Geffen, Torsten G. Blum, Stefano Aliberti, Kevin G. Blyth, Clementine Bostantzoglou, Amy Farr, Bogdan Grigoriu, Georgia Hardavella, Rudolf M. Huber, Nick Maskell, Gilbert Massard, Najib M. Rahman, Daiana Stolz, Jan van Meerbeeck Breathe, 15 (4) 279; 10.1183/20734735.0296-2019

Course report

Masterclass in airways disease: course report Antonio Spanevello, Omar Usmani, Batyr R. Osmonov, Kostiantyn Dmytriiev, Kseniia Suska Breathe, 15 (4) e132; 10.1183/20734735.0298-2019

Reviews

Hot topics and current controversies in non-cystic fibrosis bronchiectasis Diego Severiche-Bueno, Enrique Gamboa, Luis F. Reyes, Sanjay H. Chotirmall Breathe, 15 (4) 286; 10.1183/20734735.0261-2019
Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy Andrew W. Creamer, Alice E. Kent, Maha Albur Breathe, 15 (4) 296; 10.1183/20734735.0258-2019
Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD Steve W. Turner, Anne B. Chang, Ian A. Yang Breathe, 15 (4) 306; 10.1183/20734735.0268-2019
COPD treatment choices based on blood eosinophils: are we there yet? Brian Oliver, Katrina Tonga, David Darley, Sandra Rutting, Xin Zhang, Hui Chen, Gang Wang Breathe, 15 (4) 318; 10.1183/20734735.0254-2019
The electronic nose: emerging biomarkers in lung cancer diagnostics Wouter H. van Geffen, Kevin Lamote, Adrien Costantini, Lizza E.L. Hendriks, Najib M. Rahman, Torsten G. Blum, Jan van Meerbeeck Breathe, 15 (4) e135; 10.1183/20734735.0309-2019

Case report

A Malaysian ex-smoker with cough, breathlessness and nonresolving bronchospasm Jo Anne Lim, Natrajan Caruppaiya, Noriza Zainol Abidin, Boon Tat Khor, Tharmalingam Palanivelu, Sunita Devi Hukam Gopal Chand, Aznita Ibrahim Breathe, 15 (4) 324; 10.1183/20734735.0224-2019

Early career forum

In the spotlight: first ERS Early Career Member Award winner, the ERS Lung Science Conference 2020 and new ECMC members Thomas Janssens, Olivier Burgy, Sara Rolandsson Enes, Jana De Brandt Breathe, 15 (4) 330; 10.1183/20734735.0253-2019
ERS International Congress 2019: highlights from Best Abstract awardees Lorna E. Latimer, Marieke Duiverman, Mahmoud I. Abdel-Aziz, Gulser Caliskan, Sara M. Mensink-Bout, Alberto Mendoza-Valderrey, Aurelien Justet, Junichi Omura, Karthi Srikanthan, Jana De Brandt Breathe, 15 (4) e143; 10.1183/20734735.0330-2019

Landmark papers in respiratory medicine

Changes in FEV1 over time in COPD and the importance of spirometry reference ranges: the devil is in the detail Jane Kirkby, Raffaella Nenna, Aisling McGowan Breathe, 15 (4) 337; 10.1183/20734735.0252-2019

Journal club

Model for predicting EGFR mutation status in lung cancer Lam Nguyen Ho, Thuong Vu Le Breathe, 15 (4) 340; 10.1183/20734735.0250-2019
Could airway basal cells be a novel predictor of mortality in IPF? Louise Organ Breathe, 15 (4) 343; 10.1183/20734735.0265-2019
Management of incidental nodules in lung cancer screening: ready for prime-time? Nikolaos I. Kanellakis, Kevin Lamote Breathe, 15 (4) 346; 10.1183/20734735.0247-2019
Initial inhaler choice in COPD: real-world evidence Thomas Jones Breathe, 15 (4) 350; 10.1183/20734735.0256-2019
Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? Victor A. Adepoju Breathe, 15 (4) 353; 10.1183/20734735.0257-2019

Meet the Assemblies

Assembly 14: clinical techniques, imaging and endoscopy Walter De Wever Breathe, 15 (4) 356; 10.1183/20734735.0218-2019

Author correction

“Protect your lungs: get vaccinated.” Breathe 2019; 15: 263–264. Breathe, 15 (4) 358; 10.1183/20734735.ELF553

Errata

“Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy” Breathe 2019; 15: 296–304. Breathe, 15 (4) e152; 10.1183/20734735.5258-2019

ELF factsheet

Pulmonary Embolism Breathe, 15 (4) 360; 10.1183/20734735.ELF154